Literature DB >> 20828573

Fas activation in adipocytes impairs insulin-stimulated glucose uptake by reducing Akt.

Stephan Wueest1, Reto A Rapold, Eugen J Schoenle, Daniel Konrad.   

Abstract

Fas (CD95) belongs to the superfamily of the tumor necrosis factor (TNF) receptors. Besides its key role in apoptosis, Fas contributes to non-apoptotic pathways such as cell proliferation and inflammation. In 3T3-L1 adipocytes, activation of Fas by Fas ligand decreased insulin-stimulated glucose uptake, without affecting cell viability. This decrease in glucose uptake was accompanied by reduced protein expression and diminished phosphorylation of Akt. Similarly, insulin-stimulated glucose incorporation and protein levels of Akt were increased in isolated adipocytes from Fas deficient mice when compared to wild-type mice. In conclusion, Fas activation in adipocytes decreases Akt expression and thereby impairs insulin sensitivity.
Copyright © 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20828573     DOI: 10.1016/j.febslet.2010.08.052

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  11 in total

Review 1.  Adipocyte dysfunction, inflammation and metabolic syndrome.

Authors:  Nora Klöting; Matthias Blüher
Journal:  Rev Endocr Metab Disord       Date:  2014-12       Impact factor: 6.514

Review 2.  Beyond adiponectin and leptin: adipose tissue-derived mediators of inter-organ communication.

Authors:  Jan-Bernd Funcke; Philipp E Scherer
Journal:  J Lipid Res       Date:  2019-06-17       Impact factor: 5.922

3.  Degradation of cIAPs contributes to hepatocyte lipoapoptosis.

Authors:  Yuko Akazawa; Maria Eugenia Guicciardi; Sophie C Cazanave; Steven F Bronk; Nathan W Werneburg; Keisuke Kakisaka; Kazuhiko Nakao; Gregory J Gores
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2013-09-05       Impact factor: 4.052

Review 4.  Genetically modified mouse models for the study of nonalcoholic fatty liver disease.

Authors:  Perumal Nagarajan; M Jerald Mahesh Kumar; Ramasamy Venkatesan; Subeer S Majundar; Ramesh C Juyal
Journal:  World J Gastroenterol       Date:  2012-03-21       Impact factor: 5.742

5.  Fas activates lipolysis in a Ca2+-CaMKII-dependent manner in 3T3-L1 adipocytes.

Authors:  Reto A Rapold; Stephan Wueest; Adrian Knoepfel; Eugen J Schoenle; Daniel Konrad
Journal:  J Lipid Res       Date:  2012-10-21       Impact factor: 5.922

6.  Fas (CD95) expression in myeloid cells promotes obesity‐induced muscle insulin resistance.

Authors:  Stephan Wueest; Rouven Mueller; Matthias Blüher; Flurin Item; Annie S H Chin; Michael S F Wiedemann; Hitoshi Takizawa; Larisa Kovtonyuk; Alexander V Chervonsky; Eugen J Schoenle; Markus G Manz; Daniel Konrad
Journal:  EMBO Mol Med       Date:  2014-01       Impact factor: 12.137

7.  Non-alcoholic fatty liver disease, vascular inflammation and insulin resistance are exacerbated by TRAIL deletion in mice.

Authors:  Siân P Cartland; Hanis H Harith; Scott W Genner; Lei Dang; Victoria C Cogger; Melissa Vellozzi; Belinda A Di Bartolo; Shane R Thomas; Leon A Adams; Mary M Kavurma
Journal:  Sci Rep       Date:  2017-05-15       Impact factor: 4.379

8.  Depot-specific differences in adipocyte insulin sensitivity in mice are diet- and function-dependent.

Authors:  Stephan Wueest; Eugen J Schoenle; Daniel Konrad
Journal:  Adipocyte       Date:  2012-07-01       Impact factor: 4.534

9.  TRAIL (TNF-related apoptosis-inducing ligand) regulates adipocyte metabolism by caspase-mediated cleavage of PPARgamma.

Authors:  M Keuper; I Wernstedt Asterholm; P E Scherer; M-A Westhoff; P Möller; K-M Debatin; G Strauss; M Wabitsch; P Fischer-Posovszky
Journal:  Cell Death Dis       Date:  2013-01-24       Impact factor: 8.469

10.  Comparative omics and feeding manipulations in chicken indicate a shift of the endocrine role of visceral fat towards reproduction.

Authors:  Susanne Bornelöv; Eyal Seroussi; Sara Yosefi; Sharon Benjamini; Shoval Miyara; Mark Ruzal; Manfred Grabherr; Nima Rafati; Anna-Maja Molin; Ken Pendavis; Shane C Burgess; Leif Andersson; Miriam Friedman-Einat
Journal:  BMC Genomics       Date:  2018-04-26       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.